Wilhite A O, Moore C H, Blass N H, Christmas J T
Department of Anesthesiology, Medical College of Virginia, Virginia Commonwealth University, Richmond.
Reg Anesth. 1994 May-Jun;19(3):164-8.
A combined bolus and continuous epidural infusion technique of opioid and bupivacaine mixture has been described, although no pharmacokinetic data for this technique exists. The study documents the plasma concentration profile of epidural alfentanil in parturients using this technique, and evaluates the fetal heart rate tracing for associated changes following opioid administration.
Twenty-four subjects were randomized to receive epidural alfentanil 500 micrograms in 10 mL 0.125% bupivacaine, group A, or fentanyl 50 micrograms in 10 mL 0.125% bupivacaine, group B, as a bolus dose, followed by continuous infusions of alfentanil 20 micrograms/mL in 0.125% bupivacaine (group A) or fentanyl 2 micrograms/mL in 0.125% bupivacaine (group B) for labor analgesia. Plasma drug levels for each group were examined using repeated measures analysis of covariance.
Fetal heart rate tracings were recorded throughout the study and were retrospectively analyzed by a "blinded" perinatologist. Data from fetal heart rate tracings were examined by repeated measures analysis of variance. Mean infusion rates were 9.3 +/- 2.1 mL/hour and 9.6 +/- 1.7 mL/hour for groups A and B, respectively. Mean study duration was 3.7 hours in group A, and 3.0 hours in group B. Low plasma levels precluded analysis of fentanyl data. Group A subjects exhibited stability of drug levels over time. Fetal heart rate tracings in 21 patients demonstrated no changes associated with epidural opioid infusion in either group.
With the dosage regimen used in this study, an initial epidural bolus with continuous infusion technique generates a steady state plasma concentration of alfentanil that is below levels associated with direct respiratory depression.
尽管尚无该技术的药代动力学数据,但已有关于阿片类药物与布比卡因混合液的单次推注联合持续硬膜外输注技术的描述。本研究记录了使用该技术的产妇硬膜外注射阿芬太尼后的血浆浓度曲线,并评估了阿片类药物给药后胎儿心率描记图的相关变化。
24名受试者被随机分为两组,A组接受10 mL含0.125%布比卡因的500微克阿芬太尼硬膜外注射,B组接受10 mL含0.125%布比卡因的50微克芬太尼硬膜外注射,作为单次推注剂量,随后持续输注含20微克/毫升阿芬太尼的0.125%布比卡因(A组)或含2微克/毫升芬太尼的0.125%布比卡因(B组)用于分娩镇痛。使用重复测量协方差分析检查每组的血浆药物水平。
在整个研究过程中记录胎儿心率描记图,并由一位“不知情”的围产医学专家进行回顾性分析。通过重复测量方差分析检查胎儿心率描记图的数据。A组和B组的平均输注速率分别为9.3±2.1毫升/小时和9.6±1.7毫升/小时。A组的平均研究持续时间为3.7小时,B组为3.0小时。低血浆水平使芬太尼数据无法分析。A组受试者的药物水平随时间保持稳定。21名患者的胎儿心率描记图显示两组硬膜外阿片类药物输注均未引起相关变化。
采用本研究中使用的给药方案,初始硬膜外推注联合持续输注技术可使阿芬太尼的稳态血浆浓度低于与直接呼吸抑制相关的水平。